You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK (GenomeWeb) — Invivoscribe announced today that it has submitted its LeukoStrat CDx FLT3 Mutation Assay to the US Food and Drug Administration as a companion diagnostic for Daiichi Sankyo's acute myeloid leukemia drug quizartinib.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.
As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before.